Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.9K Buy
156
+100
+179% +$18.1K 0.02% 109
2026
Q1
$8.24K Hold
56
0.01% 141
2025
Q4
$10.9K Buy
+56
New +$13.3K 0.01% 128

Other funds holding ORCL

NorthAvenue LLC's ORCL Position: Q2 2026 in Review

NorthAvenue LLC increased its Oracle (ORCL) stake by 179% in Q2 2026, buying an estimated $18.1K and bringing the position to 156 shares worth $22.9K. The position accounts for 0.02% of the portfolio, ranked #109.

NorthAvenue LLC first reported a position in ORCL in Q4 2025 and has held it in 3 quarters since. 852 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • NorthAvenue LLC held 156 shares of Oracle worth $22.9K as of Q2 2026.
  • NorthAvenue LLC bought 100 Oracle shares in Q2 2026, an estimated $18.1K.
  • Oracle made up 0.02% of NorthAvenue LLC's portfolio in Q2 2026, its #109 holding.
  • NorthAvenue LLC first reported a position in Oracle in Q4 2025 and has held it in 3 quarters since.
  • 852 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on NorthAvenue LLC's 13F filing for Q2 2026, filed 21 Jul 2026.